Stay updated on Pirfenidone in COVID-19 Clinical Trial

Sign up to get notified when there's something new on the Pirfenidone in COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pirfenidone in COVID-19 Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-06-13T22:22:03.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update in the efficacy and safety evaluation of Pirfenidone in patients with severe and critical Novel Coronavirus infection. This change may reflect new findings or developments in the clinical study regarding the treatment options for patients with the new type of coronavirus pneumonia.
    Difference
    0.1%
    Check dated 2024-06-06T14:37:27.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying inclusion and exclusion criteria for the study. Previously, no information was provided in this section.
    Difference
    19%
    Check dated 2024-05-22T21:29:53.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:37:14.000Z thumbnail image

Stay in the know with updates to Pirfenidone in COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pirfenidone in COVID-19 Clinical Trial page.